Gene therapy for cerebral vascular disease

Stroke

Volumn 27, Issue 9, 1996, Pages 1688-1693

  Heistad, Donald D ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

collateral circulation; gene targeting; genetic vectors; subarachnoid hemorrhage

Indexed keywords

CYTOKINE;

ANGIOPLASTY; ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COLLATERAL CIRCULATION; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE; VASOSPASM;

EID: 0029796019     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1688     Document Type: Review

References (26)

1. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res. 1995;77:7-13.
2. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol. 1994;267(Heart Circ Physiol 36):H1263-H1271.
3. Giordano FJ, Ping P, McKirnana MD, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O, Hammond HK. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 1996;2:534-539.
4. Nilaver G, Muldoon LL, Kross RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Proc Natl Acad Sci U S A. 1995;92:9829-9833.
5. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP, Dzau VJ. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-1141.
6. Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science. 1994;265:781-784.
7. Chang MW, Barr E, Seltzer J, Jiang Y-Q, Nabel GJ, Nabel EG, Parmacek MS, Leiden JF. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science. 1995;267:518-522.
8. Feldman LJ, Isner JM. Gene therapy for the vulnerable plaque. J Am Coll Cardiol. 1995;26:826-835.
9. Nabel EG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.
10. Finkel T, Epstein SE. Gene therapy for vascular disease. FASEB J. 1995;9:843-851.
11. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science. 1989;244:1342-1344.
12. Glorioso JC, Bender MA, Goins WF, DeLuca N, Fink DJ. Herpes simplex virus as a gene-delivery vector for the central nervous system. In: Kaplitt MG, Looewy AD, eds. Viral Vectors: Gene Therapy and Neuroscience Applications. New York, NY: Academic Press Inc; 1995;1-23.
13. Davidson BL, Allen ED, Kozarsky KF, Wilson JM, Roessler BJ. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet. 1993;3:219-223.
14. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointima hyperplasia. J Clin Invest. 1995; 96:2955-2965.
15. Byrnes AP, Rusby JE, Wood MJA, Charlton HM. Adenovirus gene transfer causes inflammation in the brain. Neuroscience. 1995;66: 1015-1024.
16. Qin L, Chavin KD, Ding H, Tahara H, Favaro JP, Woodward JE, Suzuki T, Robbins PD, Lotze MT, Bromberg J. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J lmmunol. 1996;156:2316-2323.
17. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
18. Ooboshi H, Rios CD, Chu Y, Christenson SD, Faraci FM, Davidson BL, Heistad DD. Augmented adenovirus-mediated gene transfer to atherosclerotic aorta. J Invest Med. 1996;44:282A. Abstract.
19. Christenson SD, Ooboshi H, Faraci F, Davidson BL, Heistad DD. Approaches to enhance expression after adenovirus-mediated gene transfer to carotid artery. FASEB J. 1996;10:A276. Abstract.
20. Doran SE, Ren XD, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery. 1995;36:965-970.
21. Rios CD, Ooboshi H, Piegors DJ, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer to atherosclerotic vessels: a novel approach. ArteriosclerThromb Vasc Biol. 1995;15:2241-2245.
22. Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L. Gene delivery into the central nervous system by nasal instillation in rats. Gene Therapy. 1995;2:418-423.
23. Betz AL, Yang G-Y, Davidson BL. Attenuation of stroke size of rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab. 1995; 15:547-551.
24. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
25. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol. 1995; 268:R286-R292.
26. Chen AFY, Kinoshita H, Tsutsui M, O'Brien T, Pompili VJ, Crotty TB, Katusic ZS. Effect of recombinant endothelial nitric oxide synthase gene expression on reactivity of isolated canine basilar artery. FASEB J. 1966;10:A303. Abstract.